Novo Nordisk shares drop 10% after heart attack drug trial disappoints
- Posted on July 31, 2026
- By Financial Times
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo Nordisk shares drop 10% after heart attack drug trial disappoints
Danish drugmaker has been trying to diversify beyond its blockbuster obesity treatments Wegovy and Ozempic
.jpg?mbid=social_retweet)
